3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
276
Carcinoma, Non-Small-Cell Lung
243
Neoplasms
227
Prostatic Neoplasms
185
Colorectal Neoplasms
175
Multiple Myeloma
135
Lung Neoplasms
132
Ovarian Neoplasms
118
Neoplasm Metastasis
118
Leukemia, Myeloid, Acute
107
Pancreatic Neoplasms
102
Melanoma
90
Squamous Cell Carcinoma of Head and Neck
87
Recurrence
78
Endometrial Neoplasms
75
Carcinoma, Renal Cell
71
Lymphoma, Non-Hodgkin
70
Precursor Cell Lymphoblastic Leukemia-Lymphoma
67
Lymphoma
66
Stomach Neoplasms
64
Glioblastoma
63
Carcinoma, Hepatocellular
63
Brain Neoplasms
62
Glioma
60
Sarcoma
57
Head and Neck Neoplasms
57
Uterine Cervical Neoplasms
56
Triple Negative Breast Neoplasms
55
Leukemia, Lymphocytic, Chronic, B-Cell
54
Urinary Bladder Neoplasms
50
Interventions
mifamurtide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms, Bone Tissue
×
30 days
×
Clear all
NCT03643133
2026-05-19
SARCOME13
UNICANCER
Phase 2
Active not recruiting
60 enrolled